Semaglutide: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 199: | Line 199: | ||
Novikoff, Aaron et al. Why are we still in need for novel anti-obesity medications? The Lancet Regional Health – Europe, Volume 47, 101098 | Novikoff, Aaron et al. Why are we still in need for novel anti-obesity medications? The Lancet Regional Health – Europe, Volume 47, 101098 | ||
[https://doi.org/10.1016/j.lanepe.2024.101098 DOI:10.1016/j.lanepe.2024.101098]</ref>. | [https://doi.org/10.1016/j.lanepe.2024.101098 DOI:10.1016/j.lanepe.2024.101098]</ref>. | ||
==3D structures of semaglutide== | |||
[[7ki0]] - hSG + GLP-1 receptor + Gs proteins + nobody - human - Cryo EM | |||
[[7ki1]] - hTaspoglutide + GLP-1 receptor + Gs proteins + nobody - human - Cryo EM | |||
[[4zgm]] - hSG + GLP-1 receptor | |||
==Student contributors== | ==Student contributors== | ||
